Revealing variants in SARS-CoV-2 interaction domain of ACE2 and loss of function intolerance through analysis of >200,000 exomes
Cirulli, E. T.; Riffle, S.; Bolze, A.; Washington, N. L.
Show abstract
Lay summaryOur researchers took a look at a sequence of DNA known as the ACE2 gene. This gene is most well known for its role in regulating blood pressure. But in recent times, its drawn a lot of attention from the scientific community because it may also serve as a doorway of sorts, enabling viruses like SARS-CoV-2 to infect cells. Our researchers looked at the ACE2 gene in more than 200,000 people, comparing their exact DNA sequences to see where there are differences among people. Variation in the DNA sequence of a gene is common and is sometimes meaningless. But other times, small changes in the DNA sequence can alter the protein that is made from that gene. In this case the ACE2 gene makes the ACE2 protein, which is what the SARS-CoV-2 virus interacts with. We found a lot of variation between individuals and checked to see if that variation coincided with any traits (i.e., people with variant X tend to have high blood pressure more often than people without variant X). All of the traits we looked at were non-COVID-19-related traits, meaning we havent asked these people anything about COVID-19 yet (this is because these DNA sequences were collected before the pandemic). We found that there are a number of variations observed among people in a specific part of the ACE2 gene. These variations are expected to alter the shape or functionality of a specific part of the ACE2 protein: The part that interacts with the SARS-CoV-2 virus. We dont yet know what the real-life significance of this variation is, but its possible that these variants decrease the proteins ability to interact with the SARS-CoV-2 virus, thus decreasing the persons likelihood of being infected. We can speculate that there will be a spectrum of vulnerability to COVID-19 among people, where some people are more vulnerable than others, and that variants in this part of the ACE2 gene may be one of the reasons. The research we presented here shines a light on this part of the ACE2 gene and may give future researchers a direction to go in as they try to figure out what makes people vulnerable to COVID-19 and similar viruses.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- An expanded analysis framework for multivariate GWAS connects inflammatory biomarkers to functional variants and disease 96%
- Clinical case study meets population cohort: Identification of a BRCA1 pathogenic founder variant in Orcadians 94%
- Prevalence of hereditary tubulointerstitial kidney diseases in the German Chronic Kidney Disease study 93%
Similar papers in this journal
- Identification of actionable genetic variants in 4,198 Scottish volunteers from the Viking Genes research cohort and implementation of return of results 96%
- Widespread recessive effects on common diseases in a cohort of 44,000 British Pakistanis and Bangladeshis with high autozygosity 96%
- Genetic association studies using disease liabilities from deep neural networks 95%
Similar papers in this journal
- Poison exon annotations improve the yield of clinically relevant variants in genomic diagnostic testing 94%
- Utility of genome sequencing and group-enrichment to support splice variant interpretation in Marfan syndrome 94%
- Inherited variants in CHD3 demonstrate variable expressivity in Snijders Blok-Campeau syndrome 93%
Similar papers in this journal
- Genome-wide analysis in 756,646 individuals provides first genetic evidence that ACE2 expression influences COVID-19 risk and yields genetic risk scores predictive of severe disease 95%
- Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants 95%
- The UGT2A1/UGT2A2 locus is associated with COVID-19-related anosmia 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.